{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:32:28Z","timestamp":1793367148539,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009935","name":"Grocer M Kristjan Kj\u00e6r and Wife Margrethe Kj\u00e6r Born la Cour-Holmes Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005940","name":"Danish Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejso.2026.112052","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:36:01Z","timestamp":1785699361000},"page":"112052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sentinel node biopsy and survival in cutaneous melanoma: a nationwide population-based cohort study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-8849","authenticated-orcid":false,"given":"Marie B.","family":"Weitemeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-7961","authenticated-orcid":false,"given":"Neel M.","family":"Helvind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0240-4012","authenticated-orcid":false,"given":"Caroline A.","family":"Gjorup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-745X","authenticated-orcid":false,"given":"Frank","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9704-6800","authenticated-orcid":false,"given":"Pernille","family":"Bidstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9217-3907","authenticated-orcid":false,"given":"Karina D.","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Andrzej","family":"Luczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-9826","authenticated-orcid":false,"given":"Lars","family":"Bastholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-3561","authenticated-orcid":false,"given":"Henrik","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-6037","authenticated-orcid":false,"given":"Inge Marie","family":"Svane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6748-9232","authenticated-orcid":false,"given":"Eva","family":"Ellebaek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1983-5222","authenticated-orcid":false,"given":"Lisbet R.","family":"H\u00f6lmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.112052_bib1","first-page":"472","article-title":"Melanoma staging: evidence\u2010based changes in the American Joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.112052_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112052_bib3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112052_bib4","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.18.02306","article-title":"Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node","volume":"37","author":"Leiter","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2024.11.006","article-title":"Cutaneous melanoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"36","author":"Amaral","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/CMR.0000000000000073","article-title":"Sentinel node followed by completion lymph node dissection versus nodal observation: staging or therapeutic? Controversy continues despite final results of MSLT-1","volume":"24","author":"Van Akkooi","year":"2014","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2026.112052_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2014.65-c1","article-title":"MSLT-I\u2014response of clinical trial investigators","volume":"11","author":"Faries","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjd.13675","article-title":"No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the multicenter selective lymphadenectomy Trial-I final report","volume":"172","author":"Sladden","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejso.2026.112052_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejso.2016.08.007","article-title":"Sentinel node biopsy in melanoma: current controversies addressed","volume":"43","author":"Madu","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jaad.2018.11.026","article-title":"Time to reconsider the role of sentinel lymph node biopsy in melanoma","volume":"80","author":"Bigby","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejso.2026.112052_bib12","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jaad.2019.03.064","article-title":"Re: \u201ctime to reconsider the role of sentinel lymph node biopsy in melanoma.\u201d","volume":"88","author":"Faries","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejso.2026.112052_bib13","doi-asserted-by":"crossref","DOI":"10.20935\/AcadOnco8184","article-title":"New paradigms in the management of melanoma throughout various stage of the disease","volume":"3","author":"van Akkooi","year":"2026","journal-title":"Academia Oncology"},{"key":"10.1016\/j.ejso.2026.112052_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1470-2045(26)00026-4","article-title":"Assessment of survival benefit from sentinel node biopsy for melanoma: a systematic review and meta-analysis","volume":"27","author":"Varey","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jdv.13824","article-title":"Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta\u2010analysis","volume":"31","author":"Santos\u2010Juanes","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejso.2026.112052_bib16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant\u2013adjuvant or adjuvant-only pembrolizumab in advanced melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112052_bib17","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa2402604","article-title":"Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma","volume":"391","author":"Blank","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112052_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/CLEP.S99484","article-title":"The Danish melanoma database","volume":"8","author":"H\u00f6lmich","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ejso.2026.112052_bib19","unstructured":"The Danish Melanoma Group. Clinical practice guideline: adjuvant treatment of melanoma. Version 1.1. Guideline in Danish The Danish Multidisciplinary Cancer Group. Accessed June 21, 2026. https:\/\/www.dmcg.dk\/kliniske-retningslinjer\/kliniske-retningslinjer-opdelt-paa-dmcg\/melanom\/onkologisk-behandling\/adjuverende-behandling-af-melanom\/."},{"key":"10.1016\/j.ejso.2026.112052_bib20","unstructured":"The Danish Melanoma Group. Clinical practice guideline: sentinel node biopsy procedure for Melanoma. Version 1.1. Guideline in Danish The Danish Multidisciplinary Cancer Group. Accessed October 6, 2025. https:\/\/www.dmcg.dk\/kliniske-retningslinjer\/kliniske-retningslinjer-opdelt-paa-dmcg\/melanom\/kirurgisk-behandling\/sentinel-node-biopsi-procedure-for-melanom\/."},{"key":"10.1016\/j.ejso.2026.112052_bib21","unstructured":"The Danish Melanoma Group. Clinical practice guideline: lymph node pathology in cutaneous melanoma. Version 4.0. Guideline in Danish The Danish Multidisciplinary Cancer Group. Accessed April 12, 2026. https:\/\/www.dmcg.dk\/kliniske-retningslinjer\/kliniske-retningslinjer-opdelt-paa-dmcg\/melanom\/patologi\/lymfeknude-patologi\/."},{"key":"10.1016\/j.ejso.2026.112052_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish pathology register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Publ Health"},{"key":"10.1016\/j.ejso.2026.112052_bib23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2023.3256","article-title":"Stage-specific risk of recurrence and death from melanoma in Denmark, 2008-2021","volume":"159","author":"Helvind","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejso.2026.112052_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Publ Health"},{"key":"10.1016\/j.ejso.2026.112052_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2021.101943","article-title":"The Danish metastatic melanoma database (DAMMED): a nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients","volume":"73","author":"Ellebaek","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejso.2026.112052_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Publ Health"},{"key":"10.1016\/j.ejso.2026.112052_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish register of causes of death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Publ Health"},{"key":"10.1016\/j.ejso.2026.112052_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1016\/j.ejso.2026.112052_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/bimj.201800298","article-title":"On the estimation of average treatment effects with right\u2010censored time to event outcome and competing risks","volume":"62","author":"Ozenne","year":"2020","journal-title":"Biom J"},{"key":"10.1016\/j.ejso.2026.112052_bib30","series-title":"R: a language and environment for statistical computing","article-title":"R foundation for statistical computing","year":"2025"},{"key":"10.1016\/j.ejso.2026.112052_bib31","unstructured":"The Danish Health Data Authority. Transfer of analysis results. Guidance in Danish The Danish Health Data Authority. Accessed October 6, 2025. https:\/\/sundhedsdatastyrelsen.dk\/data-og-registre\/forskerservice\/forskermaskinen\/hjemsendelse-af-analyseresultater."},{"key":"10.1016\/j.ejso.2026.112052_bib32","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-019-07204-2","article-title":"Trends in sentinel lymph node biopsy enactment for cutaneous melanoma","volume":"26","author":"El Sharouni","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib33","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1245\/s10434-021-10212-w","article-title":"Assessment of frailty can guide decision making for utilization of sentinel lymph node biopsy in patients with thick melanoma","volume":"28","author":"Sharma","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib34","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1245\/s10434-024-15684-0","article-title":"The utility of sentinel lymph node biopsy in elderly patients with melanoma","volume":"31","author":"Kakish","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jclinepi.2022.03.022","article-title":"The charlson comorbidity index: problems with use in epidemiological research","volume":"148","author":"Drosdowsky","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejso.2026.112052_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(26)00180-4","article-title":"On the survival benefit from sentinel node biopsy for melanoma","volume":"27","author":"Grunhagen","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib37","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-026-19776-x","article-title":"Perspective editorial: assessment of survival benefit from sentinel node biopsy for melanoma: a systematic review and meta-analysis","author":"Bartlett","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2018.12.002","article-title":"The real-world impact of modern treatments on the survival of patients with metastatic melanoma","volume":"108","author":"Donia","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2026.112052_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SLA.0000000000000500","article-title":"Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution","volume":"260","author":"Van Der Ploeg","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.112052_bib40","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1245\/s10434-014-3954-5","article-title":"The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma","volume":"21","author":"Kachare","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib41","first-page":"835","article-title":"Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial","volume":"157","author":"Crystal","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2026.112052_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ncponc1014","article-title":"Prognostic false-positivity of the sentinel node in melanoma","volume":"5","author":"Thomas","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib43","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112052_bib44","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112052_bib45","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41591-023-02583-2","article-title":"Adjuvant nivolumab in resected stage IIB\/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial","volume":"29","author":"Kirkwood","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2026.112052_bib46","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1200\/JCO.23.02355","article-title":"Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: final analysis of distant metastasis-free survival in the phase III KEYNOTE-716 study","volume":"42","author":"Luke","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib47","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.annonc.2025.03.021","article-title":"Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma","volume":"36","author":"Grover","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2026.112052_bib48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamadermatol.2025.0318","article-title":"Global applicability of a risk prediction tool for sentinel node positivity in patients with primary cutaneous melanoma","volume":"161","author":"Lo","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejso.2026.112052_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104816","article-title":"Predictive performance of the clinicopathologic gene expression profile (CP-GEP) in identifying cutaneous melanoma patients for whom sentinel lymph node biopsy is unnecessary: a systematic review and meta-analysis","volume":"214","author":"Wong","year":"2025","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:45:12Z","timestamp":1793364312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326006712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0748798326006712"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112052","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel node biopsy and survival in cutaneous melanoma: a nationwide population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112052"}}